{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:28Z","timestamp":1786990948733,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"vor","delay-in-days":175,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Myoepithelial carcinoma and proximal-type epithelioid sarcoma of the vulva are two rare malignancies with known aggressive behavior. In addition to a similar clinical course, these two disease entities also have significant histologic and pathologic overlap. Given the rarity of these malignancies, there is limited literature on the appropriate treatment regimen. Nevertheless, there is a consensus that early surgical resection is beneficial in both cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation:<\/jats:title>\n                    <jats:p>We present a case of a patient who was initially diagnosed with myoepithelial carcinoma of the vulva with a differential later expanded to include possible epithelioid sarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>We demonstrate the importance in early identification of a SMARCB1 deficiency. Additionally, we suggest an appropriate treatment regimen for these patients going forward. Specifically, we encourage consideration of bilateral superficial and deep inguinal lymphadenectomies. Furthermore, sarcoma based chemotherapy regimens in the appropriate clinical setting may be beneficial in treating SMARCB1 deficient tumors. Additionally, there are now clinical trials involving EZH2 Inhibitors which may offer benefit for similar patients going forward.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case highlights the difficulty in making a definitive diagnosis, and the importance in identifying a SMARCB1 deficiency as it will affect treatment options and may allow for enrollment in ongoing clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2018.06.016","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:52:18Z","timestamp":1530035538000},"page":"239-243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Myoepithelial carcinoma or epithelioid sarcoma - A rare diagnosis with poor prognosis. A case report and review of literature"],"prefix":"10.1097","volume":"49","author":[{"given":"Kristina","family":"Khazeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"LaBove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breelyn","family":"Wilky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Chim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Yakoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-55-20260114","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5858\/133.5.814","article-title":"Epithelioid sarcoma","volume":"133","author":"Armah","year":"2009","journal-title":"Arch. Pathol. Lab. Med"},{"key":"R2-55-20260114","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/PAS.0b013e31805f6775","article-title":"Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases","volume":"31","author":"Gleason","year":"2007","journal-title":"Am. J. Surg. Pathol"},{"key":"R3-55-20260114","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1447-0756.2010.01392.x","article-title":"Primary myoepithelial carcinoma of the vulva and review of the literature","volume":"37","author":"Miyata","year":"2011","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"R4-55-20260114","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0000000000000397","article-title":"SMARCB1-deficient vulvar neoplasms: a clinicopathologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"39","author":"Folpe","year":"2015","journal-title":"Am. J. Surg. Pathol"},{"key":"R5-55-20260114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gore.2016.01.001","article-title":"Epithelioid sarcoma of the vulva and its clinical implication: a case report and review of the literature","volume":"15","author":"Han","year":"2016","journal-title":"Gynecol. Oncol. Rep"},{"key":"R6-55-20260114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijsu.2016.08.014","article-title":"The SCARE statement: consensus-based surgical case report guidelines","volume":"34","author":"Agha","year":"2016","journal-title":"Int. J. Surg"},{"key":"R7-55-20260114","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-012-1335-7","article-title":"Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues","volume":"461","author":"Rekhi","year":"2012","journal-title":"Virchows Arch"},{"key":"R8-55-20260114","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1746-1596-8-122","article-title":"Vulvar \"proximal-type\" epithelioid sarcoma: report of a case and review of the literature","volume":"8","author":"Patrizi","year":"2013","journal-title":"Diagn. Pathol"},{"key":"R9-55-20260114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"R10-55-20260114","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1470-2045(06)70619-2","article-title":"Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel","volume":"7","author":"Noronha","year":"2006","journal-title":"Lancet Oncol"},{"key":"R11-55-20260114","first-page":"24","article-title":"Myoepithelial carcinoma of the head and neck: a report of 23 cases and literature review","volume":"2","author":"Xu","year":"2014","journal-title":"Cancer Treat. Commun"},{"key":"R13-55-20260114","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"R15-55-20260114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fonc.2015.00189","article-title":"Scientific rationale supporting the clinical development strategy for the investigational Aurora A kinase inhibitor alisertib in cancer","volume":"5","author":"Niu","year":"2015","journal-title":"Front. Oncol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218302189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218302189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201849000-00055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:39:26Z","timestamp":1768397966000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201849000-00055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":13,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2018.06.016","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}